ECSP20069005A - Sistemas, métodos y composición de uso de mutantes de rnasa iii para producir sarn para controlar infección por patógeno huésped - Google Patents

Sistemas, métodos y composición de uso de mutantes de rnasa iii para producir sarn para controlar infección por patógeno huésped

Info

Publication number
ECSP20069005A
ECSP20069005A ECSENADI202069005A ECDI202069005A ECSP20069005A EC SP20069005 A ECSP20069005 A EC SP20069005A EC SENADI202069005 A ECSENADI202069005 A EC SENADI202069005A EC DI202069005 A ECDI202069005 A EC DI202069005A EC SP20069005 A ECSP20069005 A EC SP20069005A
Authority
EC
Ecuador
Prior art keywords
methods
systems
iii mutants
rnasa
sarn
Prior art date
Application number
ECSENADI202069005A
Other languages
English (en)
Inventor
Erick Lebrun
Timothy Travers
Guohua Yin
Original Assignee
Pebble Labs Usa Inc [Us/Us]
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pebble Labs Usa Inc [Us/Us] filed Critical Pebble Labs Usa Inc [Us/Us]
Publication of ECSP20069005A publication Critical patent/ECSP20069005A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/60—Isolated nucleic acids
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
    • A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111—General methods applicable to biologically active non-coding nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases RNAses, DNAses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering N.A.
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00—Applications; Uses
    • C12N2320/50—Methods for regulating/modulating their activity
    • C12N2320/51—Methods for regulating/modulating their activity modulating the chemical stability, e.g. nuclease-resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/26—Endoribonucleases producing 5'-phosphomonoesters (3.1.26)
    • C12Y301/26003—Ribonuclease III (3.1.26.3)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención incluye sistemas, métodos y composiciones para la generación de moléculas de sARN mediante el uso de mutantes de RNasa III seleccionados. En una forma de realización preferida, la invención incluye sistemas, métodos y composiciones para la generación de moléculas de sARN mediante el uso de mutantes de RNasa III para controlar un patógeno huésped a través de la producción y la difusión de moléculas de sARN que pueden iniciar una respuesta de la vía de ARNi dirigida a un patógeno huésped. Las formas de realización adicionales de la presente invención incluyen sistemas, métodos y composiciones para la generación independiente de DICER de moléculas de sARN mediante el uso de mutantes de RNasa III seleccionados.
ECSENADI202069005A 2018-03-31 2020-10-28 Sistemas, métodos y composición de uso de mutantes de rnasa iii para producir sarn para controlar infección por patógeno huésped ECSP20069005A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862651143P 2018-03-31 2018-03-31

Publications (1)

Publication Number Publication Date
ECSP20069005A true ECSP20069005A (es) 2020-11-30

Family

ID=68060479

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202069005A ECSP20069005A (es) 2018-03-31 2020-10-28 Sistemas, métodos y composición de uso de mutantes de rnasa iii para producir sarn para controlar infección por patógeno huésped

Country Status (12)

Country Link
US (2) US11800872B2 (es)
EP (1) EP3775188A4 (es)
CN (1) CN112585260A (es)
AU (1) AU2019245479A1 (es)
CA (1) CA3095489A1 (es)
CO (1) CO2020013533A2 (es)
EC (1) ECSP20069005A (es)
MX (1) MX2020010360A (es)
PE (1) PE20211654A1 (es)
PH (1) PH12020551599A1 (es)
SG (1) SG11202009631WA (es)
WO (1) WO2019191785A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110857438B (zh) * 2018-08-20 2022-05-17 中国烟草总公司黑龙江省公司牡丹江烟草科学研究所 一种高效产生siRNA的烟草花叶病毒基因片段、弱毒疫苗、制备方法及其应用
WO2021173953A1 (en) * 2020-02-26 2021-09-02 Pebble Labs, Inc. Novel plant endophytic bacteria and methods to control plant pathogens and pests

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998044137A2 (en) 1997-04-03 1998-10-08 Novartis Ag Plant pest control
EP1084709A1 (en) 1999-09-17 2001-03-21 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Oral recombinant lactobacilli vaccines
US20040029275A1 (en) 2002-08-10 2004-02-12 David Brown Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
EP1706511A4 (en) * 2004-01-23 2010-04-07 New England Biolabs Inc COMPOSITIONS AND METHOD FOR GENERATING SHORT DOUBLE-STRENGTH RNA USING MUTED RNASE III
WO2014110205A1 (en) * 2013-01-11 2014-07-17 Children's Medical Center Corporation Methods and compositions for the production of sirnas
JP6569530B2 (ja) * 2013-10-02 2019-09-04 味の素株式会社 ヘパロサン生産細菌及びヘパロサンの製造法

Also Published As

Publication number Publication date
US11800872B2 (en) 2023-10-31
US20210017523A1 (en) 2021-01-21
EP3775188A1 (en) 2021-02-17
SG11202009631WA (en) 2020-10-29
WO2019191785A1 (en) 2019-10-03
CO2020013533A2 (es) 2020-11-10
EP3775188A4 (en) 2022-02-09
CA3095489A1 (en) 2019-10-03
AU2019245479A1 (en) 2020-10-29
PE20211654A1 (es) 2021-08-24
CN112585260A (zh) 2021-03-30
MX2020010360A (es) 2020-10-19
PH12020551599A1 (en) 2021-08-16
US20230354822A1 (en) 2023-11-09

Similar Documents

Publication Publication Date Title
CO2019003154A2 (es) Anticuerpos anti-pd-1 y sus usos
CY1124845T1 (el) Μεθοδοι παροχης μονοκλωνου rna
CL2020001575A1 (es) Anticuerpos anti-trem2 y métodos relacionados.
CO2018010458A2 (es) Composiciones y anticuerpos anti-tim-3
SV2018005619A (es) Composiciones de oligonucleotidos y metodos de los mismos
CL2017002831A1 (es) Extensibilidad del asistente digital a aplicaciones de terceros
BR112016026950A2 (pt) composições de rnai para angiotensinogênio (agt) e métodos de uso das mesmas
CR20180605A (es) Anticuerpos anti-cd40 y sus usos
CU20160187A7 (es) (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13, 13a-octahidro-2,5-metanopirido[1',2':4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio
BR112018010605A2 (pt) nanoemulsões de bebidas produzidas por processamento de alto cisalhamento
AR095233A1 (es) Métodos y composiciones para el control de malezas
CR20190150A (es) Formulaciones de anticuerpos inhibidores de masp-2 altamente concentrados, de baja viscosidad, kits, y métodos
PE20150646A1 (es) Metodos de tratamiento de una tauopatia
CO2017011238A2 (es) Anticuerpos anti-c1s humanizados
ECSP20069005A (es) Sistemas, métodos y composición de uso de mutantes de rnasa iii para producir sarn para controlar infección por patógeno huésped
BR112018075027A2 (pt) métodos de fabricação de aplicadores de precisão
CL2021000855A1 (es) Replicones basados en alfavirus para la administración de bioterapias.
CR20170518A (es) Neutralización del virus chikungunya mediada por anticuerpos.
CL2016002223A1 (es) Microorganismo recombinante que expresa análogos de avermectina y uso de los mismos.
CO2021018034A2 (es) Oligonucleótidos gapmer modificados y métodos de uso
BR112016023729A2 (pt) espelho de veículo e método para a fabricação de tal espelho
BR112018014355A2 (pt) processos para a preparação de f-benzoxazinorifamicina i e para a preparação de 2-amino-5-fluorobenzeno-1,3-diol iii
CO2019003427A2 (es) Métodos para mejorar el resabio de bebidas alcohólicas usando alulosa
AR112587A1 (es) Psicosa-6-fosfato fosfatasa, composición para producir d-psicosa que comprende la enzima y métodos para producir d-psicosa utilizando la enzima
BR112019023394A2 (pt) Sistemas e métodos para a preparação de bebidas contendo etanol